Economic Burden Associated With Parkinson Disease in the United States.

The article presents a study on the medical cost's estimation in the treatment of Parkinson disease (PD), a common neurodegenerative disease in older adults, in the U.S. This has been anticipated to help policymakers on the distribution of funds that will ease the financial burden on the therapeutic treatment for the PD population. The study is importance because medical cost is one factor that will determine the treatment progression of a patient.